510(k) K925355
K925355 is an FDA 510(k) premarket notification submitted by Princeton Biomedix for the device "BIOSIGN(TM_ RUBELLA - RUBELLA ANTIBODY TEST". The FDA issued a decision of Substantially Equivalent on Jul 12, 1994. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Princeton Biomedix has 13 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 12, 1994
- Date Received
- Oct 22, 1992
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, Rubella
- Device Class
- Class II
- Regulation Number
- 866.3510
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Princeton Biomedix? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.